Quanterix Corporation (QTRX) News

Quanterix Corporation (QTRX): $14.91

0.09 (+0.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter QTRX News Items

QTRX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

QTRX News Highlights

  • QTRX's 30 day story count now stands at 3.
  • Over the past 11 days, the trend for QTRX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.

Latest QTRX News From Around the Web

Below are the latest news stories about QUANTERIX CORP that investors may wish to consider to help them evaluate QTRX as an investment opportunity.

Bullish Quanterix Corporation (NASDAQ:QTRX) insiders filled their treasuries with US$5.6m worth of stock over last year

Quite a few insiders have dramatically grown their holdings in Quanterix Corporation ( NASDAQ:QTRX ) over the past 12...

Yahoo | January 20, 2023

Quanterix Announces Appointment of Brian Blaser to Board of Directors

BILLERICA, Mass., January 09, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023.

Yahoo | January 9, 2023

Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test

BILLERICA, Mass., January 09, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory Developed Test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum as an aid in the evaluation of individuals for possible neurodegenerative conditions or other causes of neuronal or central nervous system damage.

Yahoo | January 9, 2023

Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference

BILLERICA, Mass., January 03, 2023--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the 41st Annual J.P. Morgan Healthcare Conference. Quanterix’s session will take place on Thursday, Jan. 12, 2023, at 12 p.m., PST and will be made available to attendees and the general public. In addition to the session, the company will also be hosting one-on

Yahoo | January 3, 2023

Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

BILLERICA, Mass., December 05, 2022--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s disease (AD). The findings were presented at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) conference held in San Francisco, CA from November 29 to December 2, 2022.

Yahoo | December 5, 2022

Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force

BILLERICA, Mass., November 16, 2022--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced plans to participate in the upcoming 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force in San Francisco, California from November 29 to December 2, 2022. Quanterix CEO Masoud Toloue is scheduled to present on Tuesday, November 29 at 9:55 a.m. PST, along with a panel of assay industry leaders, on leveraging the us

Yahoo | November 16, 2022

Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

BILLERICA, Mass., November 10, 2022--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue and Chief Financial Officer Michael Doyle will present at the CG MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17, 2022 at 4:30 p.m. EST in Boston, MA. Toloue will also host one-on-one and group meetings with institutional investors tha

Yahoo | November 10, 2022

Quanterix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

Quanterix ( NASDAQ:QTRX ) Third Quarter 2022 Results Key Financial Results Revenue: US$26.6m (down 3.8% from 3Q 2021...

Yahoo | November 10, 2022

Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) delivered earnings and revenue surprises of 4.76% and 18.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 8, 2022

Quanterix Corporation Releases Operating Results for Third Quarter 2022

BILLERICA, Mass., November 08, 2022--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced operating results for the three months ended September 30, 2022.

Yahoo | November 8, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6462 seconds.